Coşkun DOĞAN, Nesrin KIRAL, Elif TORUN PARMAKSIZ, Seda Beyhan SAĞMEN, Ali FİDAN, Banu SALEPÇİ, Sevda ŞENER CÖMERT

Akciğerin sarkomatoid karsinomlarının klinik ve radyometabolik özellikleri

Amaç: Akciğerin sarkomatoid karsinomlarının (SK) klinik ve radyometabolik (PET-BT) özelliklerinin incelenmesi ve bu özelliklerin sağ kalım üzerine etkisini araştırmak. Gereç ve Yöntem: Ocak 2014-Aralık 2016 arasında akciğer kanseri tanısı alan olguların kayıtları retrospektif olarak incelendi. Küçük hücreli dışı akciğer kanseri (KHDAK) ve SK tanısı alan olguların dosyaları ayrıldı. Bu olguların klinik ve radyometabolik özellikleri birbirleri ile karşılaştırıldı. Gruplara ait veriler Ki Kare, Mann Whitney U ile karşılaştırıldı. Sağ kalım analizleri Kaplan-Meier, Logrank yöntemi ile hesaplandı. Tüm testlerde p

Objective: To investigate the clinical and radiometabolic (PET-CT) characteristics of lung sarcomatoid carcinomas (SC) and to investigate the effect on survival. Material and Methods: Patients diagnosed with lung cancer between January 2014 and December 2016 were retrospectively analyzed. Clinical and radiometabolic characteristics of non-small cell lung carcinoma and sarcomatoid cancer were compared with each other. All data was analyzed by Chi square, Mann Whitney U, Kaplan-Meier Logrank method. In all tests p

PDF

___

Travis WD, Brambilla E, Nicholson AG, et al. WHO Panel. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol 2015; 10: 1243-60.

Kefeli M, Yıldız L, Oğuz A, Uzun O, Kandemir B. Akciğerin sarkomatoid karsinomları: Üç olgu sunumu. Türk Patoloji Dergisi 2008; 24: 64-8.

Uğurluer G, Atalar B, İkizler HAS ve ark. Serviks Kanserli Hastalarda PET/BT Tetkikinde Primer Tümörün FDG Tutulum Derecesi ile Lenf Nodu Metastazı Arasındaki İlişki. ACU Sağlık Bil Derg 2016; 3: 129-33.

Sönmezoğlu K. Akciğer kanserlerinde FDG-PET uygulamaları. Tüberküloz ve Toraks Dergisi 2005; 53: 94-112.

Cox BL, Mackie TR, Eliceiri KW. The sweet spot: FDG and other 2-carbon glucose analogs for multi-modal metabolic imaging of tumor metabolism.Am J Nucl Med Mol Imaging 2014; 5: 1-13.

Rapicetta C, Lococo F, Stefani A, et al. Primary Sarcomatoid Carcinoma of the Lung: Radiometabolic ((18)F-FDG PET/ CT) Findings and Correlation with Clinico-Pathological and Survival Results. Lung 2016; 194: 653-7.

Zhang Y, Li B, Shi H, Cai L, Gu Y. Sarcomatoid carcinoma of the lung mimics aspergilloma on ¹⁸F-FDG PET/CT. Hell J Nucl Med 2015; 18: 268-70.

Nakajima M, Kasai T, Hashimoto H, Iwata Y, Manabe H. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases. Cancer 1999; 86: 608-16.

Shen XY, Lin ZF, Lin Q, et al. Pulmonary sarcomatoid carcinoma: a case report. Contemp Oncol (Pozn) 2013; 17: 210–3.

Vieira T, Girard N, Ung M, et al. Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma. J Thorac Oncol 2013; 8: 1574-7.

Giroux Leprieur E, Lavole A, Ruppert A-M, et al. Factors associated with long-term survival of patients with advanced non-small cell lung cancer. Respirology 2012; 17: 134-42.

Vieira T, Girard N, Ung M, et al. Efficacy of firstline chemotherapy in patients with advanced lung sarcomatoid carcinoma. J Thorac Oncol 2013; 8: 1574–7.

Roesel C, Terjung S, Weinreich G, et al. Sarcomatoid carcinoma of the lung: a rare histological subtype of non-small cell lung cancer with a poor prognosis even at earlier tumour stages. Interact Cardiovasc Thorac Surg 2017; 24: 407-13.

Martin LW, Correa AM, Ordonez NG, et al. Sarcomatoid carcinoma of the lung: a predictor of poor prognosis. Ann Thorac Surg 2007; 84: 973-80.

Steuer CE, Behera M, Liu Y, et al. Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base. Clin Lung Cancer 2017; 18: 286-92.

Chang YL, Lee YC, Shih JY, Wu CT. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer 2001; 34: 91-7.

Fishback NF, Travis WD, Moran CA, et al. Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. Cancer 1994; 73: 2936-45.

Rossi G1, Cavazza A, Sturm N, et al. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol 2003; 27: 311-24.

Weissferdt A, Kalhor N, Correa AM, Moran CA. "Sarcomatoid" carcinomas of the lung: a clinicopathological study of 86 cases with a new perspective on tumor classification. Hum Pathol 2017; 63: 14-26.

Paesmans M. Facteurs pronostiques du cancer bronchique. Prognostic factors in lung cancer. Rev Mal Respir 2005; 22: 76–80

Mochizuki T, Ishii G, Nagai K, et al. Pleomorphic carcinoma of the lung: clinicopathologic characteristics of 70 cases. Am J Surg Pathol 2008; 32: 1727-35.

Paesmans M, Garcia C, Wong CY, et al. Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data. Eur Respir J 2015; 46: 1751-61.

Ciarallo A, Makis W, Novales-Diaz JA, Lisbona R. Sarcomatoid carcinoma (carcinosarcoma) of the lung mimics malignant pleural mesothelioma on 18F-FDG PET/CT: a report of 2 cases. Clin Nucl Med 2012; 37: 416-9.

Pelosi G, Sonzogni A, De Pas T, et al. Review article: pulmonary sarcomatoid carcinomas: a practical overview. Int J Surg Pathol 2010; 18: 103-20.